| Lai Ping Lew-zeisel, MD | |
|
246 Clifton Ave, Clifton, NJ 07011-1900 | |
| (973) 478-9299 | |
| (973) 478-9652 |
| Full Name | Lai Ping Lew-zeisel |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 246 Clifton Ave, Clifton, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134202831 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 215664 (New York) | Secondary |
| 208000000X | Pediatrics | 25MA08243500 (New Jersey) | Primary |
| Entity Name | Summit Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942254347 PECOS PAC ID: 5395642276 Enrollment ID: O20031218000011 |
News Archive
KemPharm, Inc. announced today that it has received a Notice of Issuance from the United States Patent and Trademark Office (USPTO) for its patent application entitled "Non-Standard Amino Acid Conjugates of Amphetamine and Processes for Making and Using the Same", U.S. Patent No. 7,776,917 B2. This patent, combined with KemPharm's recently issued U.S. Patent No. 7,772,222, provides broad protection of the Company's Ligand Activated Therapy (LAT) prodrug technology platform and its application to the treatment of Attention Deficit – Hyperactivity Disorder.
Two-thirds of patients stopped using Uprima, a drug commonly prescribed for erection problems, because they felt it wasn't effective, according to a large-scale study published in the July issue of the urology journal BJU International.
Phoenix-based Biomarker Technologies announced the launch of a clinical study for its revolutionary blood test that detects breast cancer. Previous clinical studies have shown the test to significantly exceed the accuracy of mammograms.
Scientists at Seattle Children's Research Institute have discovered an area of the brain that could control a person's motivation to exercise and participate in other rewarding activities - potentially leading to improved treatments for depression.
The immune system's killer cells deliver a tightly controlled, 3-phase knockout punch that kills intracellular parasites through a novel pathway that an international team led by researchers from the Program in Cellular and Molecular Medicine (PCMM) at Boston Children's Hospital have named "microptosis."
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lai Ping Lew-zeisel, MD 246 Clifton Ave, Clifton, NJ 07011-1900 Ph: (973) 478-9299 | Lai Ping Lew-zeisel, MD 246 Clifton Ave, Clifton, NJ 07011-1900 Ph: (973) 478-9299 |
News Archive
KemPharm, Inc. announced today that it has received a Notice of Issuance from the United States Patent and Trademark Office (USPTO) for its patent application entitled "Non-Standard Amino Acid Conjugates of Amphetamine and Processes for Making and Using the Same", U.S. Patent No. 7,776,917 B2. This patent, combined with KemPharm's recently issued U.S. Patent No. 7,772,222, provides broad protection of the Company's Ligand Activated Therapy (LAT) prodrug technology platform and its application to the treatment of Attention Deficit – Hyperactivity Disorder.
Two-thirds of patients stopped using Uprima, a drug commonly prescribed for erection problems, because they felt it wasn't effective, according to a large-scale study published in the July issue of the urology journal BJU International.
Phoenix-based Biomarker Technologies announced the launch of a clinical study for its revolutionary blood test that detects breast cancer. Previous clinical studies have shown the test to significantly exceed the accuracy of mammograms.
Scientists at Seattle Children's Research Institute have discovered an area of the brain that could control a person's motivation to exercise and participate in other rewarding activities - potentially leading to improved treatments for depression.
The immune system's killer cells deliver a tightly controlled, 3-phase knockout punch that kills intracellular parasites through a novel pathway that an international team led by researchers from the Program in Cellular and Molecular Medicine (PCMM) at Boston Children's Hospital have named "microptosis."
› Verified 5 days ago
Tadeusz Jedlinski, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 50 Mount Prospect Ave, Ste.202, Clifton, NJ 07013 Phone: 973-458-0407 Fax: 973-458-0889 | |
Katlyne Lubin, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1135 Broad St, Clifton, NJ 07013 Phone: 888-244-5373 Fax: 973-365-3089 | |
Jagdish Seth, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1115 Clifton Ave Ste 101, Clifton, NJ 07013 Phone: 973-250-2970 | |
Mirian Dolores Lugo, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 344 Clifton Ave, Clifton, NJ 07011 Phone: 973-435-4545 Fax: 973-928-1899 | |
Janette Basta, Pediatrics Medicare: Medicare Enrolled Practice Location: 1035 Us Highway 46, Clifton, NJ 07013 Phone: 973-249-9620 | |
Dr. Deniz Burton, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 296 Clifton Ave, Clifton, NJ 07011 Phone: 973-249-8211 |